Shanghai Xuerong Bio-Technology Co Ltd (SHE:300511) — Market Cap & Net Worth
Market Cap & Net Worth: Shanghai Xuerong Bio-Technology Co Ltd (300511)
Shanghai Xuerong Bio-Technology Co Ltd (SHE:300511) has a market capitalization of $482.95 Million (CN¥3.30 Billion) as of August 1, 2026. Listed on the SHE stock exchange, this China-based company holds position #12199 globally and #3485 in its home market, demonstrating a 1.98% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shanghai Xuerong Bio-Technology Co Ltd's stock price CN¥5.15 by its total outstanding shares 640847016 (640.85 Million). See Shanghai Xuerong Bio-Technology Co Ltd (300511) reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
Shanghai Xuerong Bio-Technology Co Ltd Market Cap History: 2016 to 2026
Shanghai Xuerong Bio-Technology Co Ltd's market capitalization history from 2016 to 2026. Data shows change from $1.52 Billion to $482.95 Million (-4.30% CAGR).
Shanghai Xuerong Bio-Technology Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shanghai Xuerong Bio-Technology Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.15x
Shanghai Xuerong Bio-Technology Co Ltd's market cap is 0.15 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.52 Billion | $998.68 Million | $104.81 Million | 1.52x | 14.47x |
| 2017 | $1.14 Billion | $1.33 Billion | $122.41 Million | 0.86x | 9.34x |
| 2018 | $539.26 Million | $1.85 Billion | $151.46 Million | 0.29x | 3.56x |
| 2019 | $619.79 Million | $1.96 Billion | $220.33 Million | 0.32x | 2.81x |
| 2020 | $1.21 Billion | $2.20 Billion | $247.24 Million | 0.55x | 4.88x |
| 2021 | $710.82 Million | $2.06 Billion | -$308.90 Million | 0.34x | N/A |
| 2022 | $604.86 Million | $2.32 Billion | -$287.23 Million | 0.26x | N/A |
| 2023 | $501.70 Million | $2.57 Billion | -$188.06 Million | 0.20x | N/A |
| 2024 | $325.40 Million | $2.16 Billion | -$617.07 Million | 0.15x | N/A |
Competitor Companies of 300511 by Market Capitalization
Companies near Shanghai Xuerong Bio-Technology Co Ltd in the global market cap rankings as of August 1, 2026.
Key companies related to Shanghai Xuerong Bio-Technology Co Ltd by market ranking:
- Archer-Daniels-Midland Company (NYSE:ADM): Ranked #804 globally with a market cap of $33.40 Billion USD.
- Muyuan Foodstuff Co Ltd (SHE:002714): Ranked #855 globally with a market cap of $31.38 Billion USD ( CN¥214.47 Billion CNY).
- Bunge Limited (NYSE:BG): Ranked #1243 globally with a market cap of $20.56 Billion USD.
- Tyson Foods Inc (NYSE:TSN): Ranked #1516 globally with a market cap of $16.35 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #804 | Archer-Daniels-Midland Company | NYSE:ADM | $33.40 Billion | $79.27 |
| #855 | Muyuan Foodstuff Co Ltd | SHE:002714 | $31.38 Billion | CN¥39.26 |
| #1243 | Bunge Limited | NYSE:BG | $20.56 Billion | $106.23 |
| #1516 | Tyson Foods Inc | NYSE:TSN | $16.35 Billion | $57.96 |
Shanghai Xuerong Bio-Technology Co Ltd Historical Marketcap From 2016 to 2026
Between 2016 and today, Shanghai Xuerong Bio-Technology Co Ltd's market cap moved from $1.52 Billion to $ 482.95 Million, with a yearly change of -4.30%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥482.95 Million | -17.47% |
| 2025 | CN¥585.16 Million | +79.83% |
| 2024 | CN¥325.40 Million | -35.14% |
| 2023 | CN¥501.70 Million | -17.05% |
| 2022 | CN¥604.86 Million | -14.91% |
| 2021 | CN¥710.82 Million | -41.11% |
| 2020 | CN¥1.21 Billion | +94.75% |
| 2019 | CN¥619.79 Million | +14.93% |
| 2018 | CN¥539.26 Million | -52.81% |
| 2017 | CN¥1.14 Billion | -24.66% |
| 2016 | CN¥1.52 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 1st, 2026 the market cap of Shanghai Xuerong Bio-Technology Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $482.95 Million USD |
| MoneyControl | $482.95 Million USD |
| MarketWatch | $482.95 Million USD |
| marketcap.company | $482.95 Million USD |
| Reuters | $482.95 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shanghai Xuerong Bio-Technology Co Ltd
Shanghai Xuerong Biotechnology Co.,Ltd., together with its subsidiaries, engages in the research and development, cultivation and sale of fresh edible mushrooms in the People's Republic of China. It offers enoki mushrooms; shiitake mushrooms, including oyster mushrooms, white jade mushrooms and seafood mushrooms; king oyster mushrooms; and velvet mushrooms, as well as Pleurotus eryngii and Flammu… Read more